Last reviewed · How we verify

NCT00954668: IDEAL NSTEMI

ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)

Withdrawn NA Last updated 6 July 2018
What this trial tests

NA trial testing immediate angiography and revascularization in Non-ST-elevation Myocardial Infarction. Withdrawn.

Timeline
1 January 2009
Primary endpoint
1 January 2009
1 January 2009

Quick facts

Lead sponsorUniversity of Leipzig
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date1 January 2009
Primary completion1 January 2009
Estimated completion1 January 2009
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Leipzig

Who can join

Adults 18 to 90, any sex, with Non-ST-elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The currently available evidence led to current guideline recommendations that a systematic approach of immediate angiography in NSTEMI patients stabilized with contemporary antiplatelet treatment is not mandatory. However, this immediate invasive approach is appealing because it allows treating the underlying cause (the plaque rupture) as early as possible with subsequent reduction of death and recurrent myocardial infarction. In the IDEAL NSTEMI trial we test an immediate invasive approach (\<2 h) with an approach 12-72 h according top guidelines with respect to 6 months death and mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Non-ST-elevation Myocardial Infarction

Currently open trials in the same condition.

Other University of Leipzig trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00954668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing